ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
121.127 IP-LS
Project title
First-in-Class PAM Targeting Adenosine 2A Receptor: Developmental Candidate Selection and Validation of Autoimmune Disease Indications

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Pejoski David
Adoram Therapeutics SA
www.uid.admin.ch/Detail.aspx?uid_id=CHE414015961

Scientific management
Université de Genève

Implementation Partner


Adoram Therapeutics SA
www.uid.admin.ch/Detail.aspx?uid_id=CHE414015961